Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryotaro Nakamura

Showing results (21-30 of 244) with videos related to

Pageof 25
Sort By:
Scientific Reports|September 30, 2022
siRNA-mediated gene knockdown via electroporation in hydrozoan jellyfish embryosTokiha Masuda-Ozawa, Sosuke Fujita, Ryotaro Nakamura, et al.
Nature Communications|August 1, 2024
Neuronal and non-neuronal functions of the synaptic cell adhesion molecule neurexin in Nematostella vectensisChristine Guzman, Kurato Mohri, Ryotaro Nakamura, et al.
Transfusion|October 11, 2019
RBC and platelet transfusion support in the first 30 and 100 days after haploidentical hematopoietic stem cell transplantationShan Yuan, Dongyun Yang, Ryotaro Nakamura, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 13, 2009
Donor and recipient CMV serostatus and outcome of pediatric allogeneic HSCT for acute leukemia in the era of CMV-preemptive therapyCarolyn E Behrendt, Joseph Rosenthal, Ellen Bolotin, et al.
Frontiers in Immunology|December 22, 2025
Association of pharmacokinetic biomarkers with early immune recovery following HLA-haploidentical hematopoietic cell transplantationGuofang Shen, Timothy W Synold, Shanzay Khan, et al.
British Journal of Haematology|November 18, 2003
HLA-DR4 predicts haematological response to cyclosporine in T-large granular lymphocyte lymphoproliferative disordersMinoo Battiwalla, Jos Melenhorst, Yogen Saunthararajah, et al.
Transfusion|January 15, 2024
Lack of RBC transfusion independence by Day 30 following allogeneic hematopoietic stem cell transplant strongly predicts inferior survival and high non-relapse mortality in acute myeloid leukemia patientsShan Yuan, Dongyun Yang, Ryotaro Nakamura, et al.
Expert Review of Clinical Immunology|November 3, 2023
A review of low dose interleukin-2 therapy in management of chronic graft-versus-host-diseaseAmandeep Salhotra, Leah Falk, Gabriel Park, et al.
JCO Clinical Cancer Informatics|February 4, 2021
Explainable Tree-Based Predictions for Unplanned 30-Day Readmission of Patients With Cancer Using Clinical EmbeddingsChi Wah Wong, Chen Chen, Lorenzo A Rossi, et al.
Transfusion|August 4, 2020
Red blood cell and platelet transfusion support in the first 30 and 100 days after allogeneic hematopoietic cell transplantShan Yuan, Dongyun Yang, Ryotaro Nakamura, et al.
Pageof 25

Showing results (21-30 of 244) with videos related to

Sort By:
Pageof 25
Scientific Reports|September 30, 2022
siRNA-mediated gene knockdown via electroporation in hydrozoan jellyfish embryosTokiha Masuda-Ozawa, Sosuke Fujita, Ryotaro Nakamura, et al.
Nature Communications|August 1, 2024
Neuronal and non-neuronal functions of the synaptic cell adhesion molecule neurexin in Nematostella vectensisChristine Guzman, Kurato Mohri, Ryotaro Nakamura, et al.
Transfusion|October 11, 2019
RBC and platelet transfusion support in the first 30 and 100 days after haploidentical hematopoietic stem cell transplantationShan Yuan, Dongyun Yang, Ryotaro Nakamura, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 13, 2009
Donor and recipient CMV serostatus and outcome of pediatric allogeneic HSCT for acute leukemia in the era of CMV-preemptive therapyCarolyn E Behrendt, Joseph Rosenthal, Ellen Bolotin, et al.
Frontiers in Immunology|December 22, 2025
Association of pharmacokinetic biomarkers with early immune recovery following HLA-haploidentical hematopoietic cell transplantationGuofang Shen, Timothy W Synold, Shanzay Khan, et al.
British Journal of Haematology|November 18, 2003
HLA-DR4 predicts haematological response to cyclosporine in T-large granular lymphocyte lymphoproliferative disordersMinoo Battiwalla, Jos Melenhorst, Yogen Saunthararajah, et al.
Transfusion|January 15, 2024
Lack of RBC transfusion independence by Day 30 following allogeneic hematopoietic stem cell transplant strongly predicts inferior survival and high non-relapse mortality in acute myeloid leukemia patientsShan Yuan, Dongyun Yang, Ryotaro Nakamura, et al.
Expert Review of Clinical Immunology|November 3, 2023
A review of low dose interleukin-2 therapy in management of chronic graft-versus-host-diseaseAmandeep Salhotra, Leah Falk, Gabriel Park, et al.
JCO Clinical Cancer Informatics|February 4, 2021
Explainable Tree-Based Predictions for Unplanned 30-Day Readmission of Patients With Cancer Using Clinical EmbeddingsChi Wah Wong, Chen Chen, Lorenzo A Rossi, et al.
Transfusion|August 4, 2020
Red blood cell and platelet transfusion support in the first 30 and 100 days after allogeneic hematopoietic cell transplantShan Yuan, Dongyun Yang, Ryotaro Nakamura, et al.
Pageof 25